NeueHealth, Inc. / Fundamentals

    Income statement

    Net revenue
    €629.95M
    Cost of goods sold
    €424.12M
    Gross profit
    €205.83M
    SG&A expenses
    €112.21M
    R&D expenses
    €0.00
    EBITDA
    €610.24M
    D&A
    €10.28M
    EBIT
    €375.69M
    Interest expenses
    €6.19M
    EBT
    €394.10M
    Tax expenses
    €7.01M
    Net income
    €586.77M

    Cash flow statement

    Net deferred tax
    €1.80M
    Non-cash items
    -€497.39M
    Changes in working capital
    €1.42B
    Operating cash flow
    €1.76B
    Capex
    €4.19M
    Other investing cash flow
    -€457.46M
    Net investing cash flow
    -€182.27M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    -€858.00
    Debt repayment
    €0.00
    Other financing cash flow
    €7.20M
    Net financing cash flow
    -€272.55M
    Foreign exchange effects
    -€549.28M
    Net change in cash
    €637.32M
    Cash at end of period
    €182.69M
    Free cash flow
    €1.76B

    Balance sheet

    Cash and cash equivalents
    €112.93M
    Cash and short-term investments
    €124.89M
    Total receivables
    €45.54M
    Inventory
    €0.00
    Other current assets
    €378.59M
    Total current assets
    €549.02M
    Property, plant & equipment
    €10.01M
    Goodwill
    €0.00
    Intangible assets
    €56.70M
    Long-term investments
    €0.00
    Other non-current assets
    €22.36M
    Total non-current assets
    €89.07M
    Total assets
    €638.09M
    Accounts payable
    €4.56M
    Short-term debt
    €858.00K
    Other current liabilities
    €774.00M
    Total current liabilities
    €779.42M
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €195.91M
    Total non-current liabilities
    €195.91M
    Total liabilities
    €975.33M
    Common stock
    €858.00
    Retained earnings
    -€3.83B
    Other equity
    €0.00
    Total equity
    -€1.13B
    Total liabilities and shareholders' equity
    -€199.45M

    Company information

    Market capitalization
    €36.27M
    Employees
    1.3K
    Enterprise Value
    -€76.30M

    Company ratios

    Gross margin
    32.7%
    EBITDA margin
    96.9%
    EBIT margin
    59.6%
    EBT margin
    62.6%
    Net margin
    93.1%
    ROE
    -52.1%
    ROA
    92.0%
    Asset turnover
    98.7%
    FCF margin
    278.3%
    FCF yield
    4,834.4%
    Efficiency ratio
    3.1%
    Net sales per employee
    €503.16K
    Net income per employee
    €468.66K

    Notifications